MEDI IMMO
0534.524.042 · rovalta.com · 23/09/2026
MEDI IMMO
Overview
What does MEDI IMMO do?
MEDI IMMO is a Private limited company incorporated in 2013. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Waterloo.
1410 Waterloo · WallonieSee on map
Trend over 11 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||
| Gross margin | 357,3 k € | -33.3% | 535,6 k € | +32.8% | 403,4 k € | +64.5% | 245,2 k € | -27.7% | 339,2 k € | +103% | 167,1 k € | +12.7% | 148,3 k € | +58.4% | 93,6 k € | +139% | 39,2 k € | -58.4% | 94,1 k € | +39.2% | 67,6 k € |
| EBITDA | 245,2 k € | -20.9% | 310,2 k € | -22.2% | 398,4 k € | +63.4% | 243,8 k € | -22.1% | 312,8 k € | +87.9% | 166,5 k € | +12.9% | 147,5 k € | +59.4% | 92,5 k € | +145% | 37,8 k € | -59.3% | 92,7 k € | +41.5% | 65,5 k € |
| Operating result | 199,6 k € | -30.5% | 287,3 k € | -23.5% | 375,4 k € | +71.3% | 219,1 k € | -9.4% | 241,9 k € | +58.6% | 152,5 k € | +15.9% | 131,6 k € | +76.8% | 74,4 k € | +178% | 26,7 k € | -68.0% | 83,6 k € | +34.8% | 62,1 k € |
| Net result | 81,3 k € | -64.4% | 228,1 k € | -9.6% | 252,2 k € | +61.7% | 156 k € | -8.1% | 169,8 k € | +38.2% | 122,9 k € | +67.3% | 73,5 k € | +94.0% | 37,9 k € | +282% | 9,9 k € | -79.2% | 47,7 k € | +56.0% | 30,6 k € |
| Balance sheet | |||||||||||||||||||||
| Equity | 623,8 k € | +15.0% | 542,5 k € | +30.9% | 414,4 k € | +14.4% | 362,2 k € | -11.9% | 411,2 k € | +70.3% | 241,5 k € | +104% | 118,6 k € | +163% | 45,1 k € | -0.3% | 45,3 k € | +0.0% | 45,3 k € | +64.1% | 27,6 k € |
| Total assets | 1,9 M € | +63.4% | 1,2 M € | -22.1% | 1,5 M € | +4.1% | 1,4 M € | +47.1% | 972,4 k € | +55.1% | 627 k € | +33.0% | 471,5 k € | -18.2% | 576,6 k € | +3.8% | 555,5 k € | +73.5% | 320,1 k € | -39.9% | 532,9 k € |
| Cash | 295,2 k € | +2.4% | 288,3 k € | -35.9% | 449,9 k € | +843% | 47,7 k € | -78.8% | 224,6 k € | +197% | 75,6 k € | +250% | 21,6 k € | -91.0% | 240,7 k € | -0.4% | 241,7 k € | +1121% | 19,8 k € | -87.8% | 161,9 k € |
| Debts | 1,2 M € | +123% | 532,6 k € | -50.4% | 1,1 M € | +0.6% | 1,1 M € | +90.3% | 561,1 k € | +45.6% | 385,5 k € | +9.2% | 352,9 k € | +20.8% | 292,1 k € | +14.6% | 254,9 k € | -7.3% | 274,9 k € | -45.6% | 505,3 k € |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 1 active · 3 ended
Active mandates
Ended mandates
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/07/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 | 31/12/2019 |
| Length of the financial year | 18 months | 12 months | 12 months | 12 months | 18 months | 12 months |
| Filing date | 29/08/2026 | 13/03/2025 | 17/05/2024 | 07/12/2022 | 20/09/2021 | 08/09/2020 |
| General meeting | 30/06/2026 | 10/12/2024 | 08/12/2023 | 07/12/2022 | 15/09/2021 | 30/06/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
12 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 30/06/2026 | 29/08/2026 | French | |
| Abridged model | 30/06/2024 | 10/12/2024 | 13/03/2025 | French | |
| Abridged modelCorrection | 30/06/2023 | 08/12/2023 | 17/05/2024 | French | |
| Abridged model | 30/06/2023 | 08/12/2023 | 27/12/2023 | French | |
| Abridged model | 30/06/2022 | 07/12/2022 | 07/12/2022 | French | |
| Abridged model | 30/06/2021 | 15/09/2021 | 20/09/2021 | French | |
| Abridged model | 31/12/2019 | 30/06/2020 | 08/09/2020 | French | |
| Abridged model | 31/12/2018 | 28/06/2019 | 28/06/2019 | French | |
| Abridged model | 31/12/2017 | 20/06/2018 | 20/06/2018 | French | |
| Abridged model | 31/12/2016 | 30/06/2017 | 06/07/2017 | French | |
| Abridged model | 31/12/2015 | 24/06/2016 | 21/09/2016 | French | |
| Abridged model | 31/12/2014 | 26/06/2015 | 09/09/2015 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 1 active · 3 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Registered office04/02/2026SIEGE SOCIAL
- Mandates20/01/2025STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DENOMINATION - OBJET - ASSEMBLEE GENERALE - ANNEE COMPTABLE
- Registered office23/06/2021SIEGE SOCIAL
- Other30/11/2020STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - ASSEMBLEE GENERALE - ANNEE COMPTABLE
- Registered office09/03/2017SIEGE SOCIAL
- Mandates08/06/2016DENOMINATION - OBJET - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Mandates13/02/2014SIEGE SOCIAL - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
- Other28/05/2013RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202581,3 k €↓
- 2024Annual accounts 2024228,1 k €↓
- 2024Name changeMEDI IMMO
- 2023Annual accounts 2023252,2 k €↑
- 2022Annual accounts 2022156 k €↓
- 2021Annual accounts 2021169,8 k €↑
- 2019Annual accounts 2019122,9 k €↑
- 2018Annual accounts 201873,5 k €↑
- 2017Annual accounts 201737,9 k €↑
- 2016Annual accounts 20169,9 k €↓
- 2015Annual accounts 201547,7 k €↑
- 2015Name changeMEDIPHARM DESIGN GROUP
- 2014Annual accounts 201430,6 k €
- 2014Name changeMEDI PHARMA CONSULT
- 08/05/2013IncorporationPrivate limited company